Cassandra Crapps-cromer, | |
1601 Devon Dr, Albany, GA 31721-7119 | |
(229) 291-0797 | |
Not Available |
Full Name | Cassandra Crapps-cromer |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 1601 Devon Dr, Albany, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659743201 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Cassandra Crapps-cromer, 1601 Devon Dr, Albany, GA 31721-7119 Ph: (229) 291-0797 | Cassandra Crapps-cromer, 1601 Devon Dr, Albany, GA 31721-7119 Ph: (229) 291-0797 |
News Archive
Blaming the victim, usually a female, is common in sexual assault cases, but in some places it's more prevalent than others.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Hillenbrand reported third quarter 2010 revenue of $205.8 million, a $47.1 million (30 percent) increase over the prior year, due primarily to the inclusion of revenue generated by K-Tron International, which Hillenbrand acquired April 1, 2010. Business acquisition costs and the impact of purchase accounting were the primary drivers of a $12.1 million (48 percent) decrease in net income from the prior year and a $0.19 (46 percent) decrease in earnings per share, from $0.41 to $0.22.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
› Verified 5 days ago
Susan Hardie, LPC Counselor Medicare: Medicare Enrolled Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-7001 Fax: 229-312-7006 | |
Cynthia Morrell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 506 N Jackson St, Albany, GA 31701 Phone: 229-889-7200 Fax: 229-889-7393 | |
Dena Payn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1211 Palmyra Rd, Albany, GA 31701 Phone: 229-439-8686 | |
Malcolm Rundell Bynum, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 321 William Jr St, Albany, GA 31707 Phone: 229-430-5100 | |
Mr. Roderick Mcleod Wilcox, LCSW, MFT Counselor Medicare: Accepting Medicare Assignments Practice Location: 1216 Whispering Pines Rd, Albany, GA 31707 Phone: 229-435-1729 Fax: 229-435-1720 | |
Mr. Kenneth George Myers Jr., M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1511 W 3rd Ave, Suite 104, Albany, GA 31707 Phone: 229-854-4886 | |
Kareema Williams, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 11th Ave, Albany, GA 31701 Phone: 229-430-4140 |